International journal of methods in psychiatric research · 2025
Effect of the MyDéfi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double-Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker-The SMARTBINGE Trial.
СтатьяПротокол клинического исследованияПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
André Camille, Sauton Pierre, Dreinaza Méléna, Diouf Momar, Bodeau Sandra, Martinetti Margaret, Trouillet Raphaël, de Groote Clara, Nandrino Jean-Louis, Alexandre Adèle, Benzerouk Farid, Gierski Fabien, Perney Pascal, Grellet Laure, André Judith, Naassila Mickael
Аннотация
OBJECTIVE: The purpose of this paper is to describe a study protocol of a clinical trial exploring the effectiveness of the new mobile application MyDéfi proposing personalized feedback, on both alcohol consumption and quality of life, as well as the blood alcohol exposure biomarker phosphatidylethanol, in university students displaying binge drinking behavior.
METHODS: This prospective national multicentric randomized, two-arm (1:1), double-blind controlled trial will recruit 628 students (aged 18-25 years) with binge drinking behavior. Participants will be randomized in the "intervention" group (personalized feedback) or the "control" group (generic feedback) and will undergo four monthly visits. Monthly dried blood spot sample for measuring phosphatidylethanol concentration and online questionnaires will be collected. Our primary objective is to assess the reduction weekly standard drinks, through self-report gathered via MyDéfi. Secondary objectives will evaluate the application's impact on the dosage of phosphatidylethanol blood concentration and on quality of life".
RESULTS: Recruitment started in March 2024 and will end in March 2026.
CONCLUSION: This study aims to determine the effectiveness of two versions of the same mobile application (generic vs. personalized feedback) on alcohol consumption in students displaying binge drinking behavior. The effectiveness of the application will be measured, with a secondary objective of quantifying phosphatidylethanol. Our study will open new perspectives on the use of digital interventions for students who do not actively seek treatment.
TRIAL REGISTRATION: Trial registration number (NCT06084832), the date of registration (10th October 2023) and when this was done (16th October 2023). https://clinicaltrials.gov/study/NCT06084832.
METHODS: This prospective national multicentric randomized, two-arm (1:1), double-blind controlled trial will recruit 628 students (aged 18-25 years) with binge drinking behavior. Participants will be randomized in the "intervention" group (personalized feedback) or the "control" group (generic feedback) and will undergo four monthly visits. Monthly dried blood spot sample for measuring phosphatidylethanol concentration and online questionnaires will be collected. Our primary objective is to assess the reduction weekly standard drinks, through self-report gathered via MyDéfi. Secondary objectives will evaluate the application's impact on the dosage of phosphatidylethanol blood concentration and on quality of life".
RESULTS: Recruitment started in March 2024 and will end in March 2026.
CONCLUSION: This study aims to determine the effectiveness of two versions of the same mobile application (generic vs. personalized feedback) on alcohol consumption in students displaying binge drinking behavior. The effectiveness of the application will be measured, with a secondary objective of quantifying phosphatidylethanol. Our study will open new perspectives on the use of digital interventions for students who do not actively seek treatment.
TRIAL REGISTRATION: Trial registration number (NCT06084832), the date of registration (10th October 2023) and when this was done (16th October 2023). https://clinicaltrials.gov/study/NCT06084832.